#Sustainability #India #Biomass Briquettes #Piramal Pharma #Digwal

Piramal Pharma Leads the Charge in Sustainable Manufacturing

Piramal Pharma Limited has made a transformative move towards sustainability by successfully converting its coal-fired steam boiler at the Digwal facility in India to operate on biomass briquettes. This landmark decision is anticipated to eliminate roughly 24,000 tonnes of carbon dioxide equivalent (tCO2e) greenhouse gas emissions every year, significantly aligning with the company's commitment to reducing its emissions by 42% by the year 2030.

The Rationale Behind the Transition

This transition is more than just an environmental initiative; it's part of a broader sustainability agenda that is increasingly critical not just for businesses but for the planet as a whole. Nandini Piramal, Chairperson of Piramal Pharma Ltd, highlighted that this conversion serves as a testament to the company's dedication to minimizing its environmental footprint. It also demonstrates how companies can innovate to meet global climate action goals.

“Transitioning to biomass briquettes at our Digwal facility represents our commitment to reduce our environmental footprint while fostering innovation in sustainable manufacturing. We are on course to contribute to a more sustainable future,” said Nandini Piramal.

Biomass briquettes are derived from compressed agricultural waste, thus serving a dual purpose: they not only provide a renewable energy source but also promote circular economy principles by recycling organic by-products. This is part of Piramal's larger strategy to enhance sustainability in pharmaceutical manufacturing.

A New Industry Standard

As the pharmaceutical industry faces growing pressure to adopt greener practices, Piramal Pharma is setting a benchmark for environmental responsibility. Peter DeYoung, Chief Executive Officer of Piramal Global Pharma, remarked, “This transformation at our Digwal facility underscores our commitment to environmental stewardship and sustainable operational practices.”

By adopting biomass briquettes, Piramal Pharma is not only reducing GHG emissions but also showcasing that effective climate action solutions can be integrated with operational excellence in the pharmaceutical sector.

Benefits of Biomass Briquettes

Biomass briquettes provide several advantages over traditional fossil fuels. They are carbon-neutral, meaning that the CO2 released when combusted is offset by the CO2 absorbed during the growth cycle of the biomass used to create them. This aligns perfectly with global efforts to combat climate change by reducing the carbon footprint associated with energy production. Moreover, using agricultural waste minimizes trash and leverages what would otherwise be unutilized materials.

In transitioning to biomass briquettes, Piramal Pharma demonstrates that it is possible to harmonize business growth and environmental responsibility. The company is committed to ensuring that these operations not only comply with current regulatory requirements but also lead the way in promoting best practices for sustainability.

Conclusion

Piramal Pharma Limited's shift to biomass briquettes is a significant step toward achieving a greener pharmaceutical manufacturing sector. As the company continues to pioneer sustainable practices, it hopes to inspire other pharmaceutical firms to follow suit, thus contributing to a more environmentally responsible industry. With significant emission reductions and a commitment to innovation, Piramal Pharma is poised to make a lasting impact on global health and the environment.

In a world increasingly focused on sustainability, Piramal's initiatives are a beacon of hope, proving that responsible growth is indeed attainable when companies prioritize both their bottom line and the planet.